Skip to library content
Back to the shelf
Peptide library
Not FDA-approvedBones & muscles

CJC-1295

Also called modified GRF 1-29

Evidence
Limited research
Class
GHRH analog (secretagogue)

CJC-1295 belongs to the GHRH analog (secretagogue) class. This library groups it under bones & muscles. Its source category is Not FDA-approved.

Research libraryPeppy Care
Source snapshot
References8 linked sources

At a glance

CJC-1295 research overview
Compound classGHRH analog (secretagogue)
Body systemBones & muscles
Use or research focusMuscle gain, fat loss, recovery
Regulatory statusNot FDA-approved; removed from 503A Category 2 (Apr 2026); status unsettled
Source evidence ratingLimited research

How does CJC-1295 work?

Sustained GH/IGF-1 elevation; DAC version is long-acting.

The source catalog maps this mechanism to Pituitary, Muscle, Adipose / Fat. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.

What does the evidence tell us?

The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.

Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.

Safety and considerations

For an unapproved use or compound, safety and effectiveness may be uncertain. Products sold for research are not a substitute for prescribed care. Do not infer a human dose, injection protocol, or treatment recommendation from preclinical research.

This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.

Common questions

What is CJC-1295?

CJC-1295 belongs to the GHRH analog (secretagogue) class. This library groups it under bones & muscles. Its source category is Not FDA-approved. Its recorded use or research focus is: Muscle gain, fat loss, recovery.

Is CJC-1295 FDA-approved?

The catalog records: Not FDA-approved; removed from 503A Category 2 (Apr 2026); status unsettled. Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.

How strong is the research?

The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.

Where can I read the research?

The Citations tab contains 8 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.

More for bones & muscles

Factual catalog fields and citation links are adapted from Superpower’s CJC-1295 guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.